Search
Abcellera Biologics Inc
ABCLAdd to Watchlist
5.715USD
+0.025+0.44%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.74BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Thermopylae Holdings Ltd
18.38%
Baker Bros. Advisors LP
9.01%
Capital World Investors
4.38%
Two Sigma Investments, LP
3.52%
Lecault (Veronique)
3.15%
Other
61.56%
Shareholders
Shareholders
Proportion
Thermopylae Holdings Ltd
18.38%
Baker Bros. Advisors LP
9.01%
Capital World Investors
4.38%
Two Sigma Investments, LP
3.52%
Lecault (Veronique)
3.15%
Other
61.56%
Shareholder Types
Shareholders
Proportion
Corporation
18.39%
Hedge Fund
15.77%
Investment Advisor
11.92%
Research Firm
4.81%
Investment Advisor/Hedge Fund
4.44%
Individual Investor
4.22%
Bank and Trust
1.47%
Venture Capital
0.15%
Pension Fund
0.13%
Other
38.70%
Institutional Shareholding
Updated: Sun, Apr 5
Updated: Sun, Apr 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
323
131.69M
43.14%
-19.22M
2025Q4
315
112.27M
50.73%
-101.09K
2025Q3
340
112.51M
51.75%
-3.28M
2025Q2
368
115.12M
53.94%
-18.45M
2025Q1
420
133.63M
52.62%
-23.37M
2024Q4
441
121.95M
50.14%
+4.83M
2024Q3
440
121.95M
51.59%
-4.54M
2024Q2
439
127.07M
51.27%
-6.55M
2024Q1
432
134.44M
53.43%
-22.43M
2023Q4
425
138.44M
60.93%
-1.40M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Thermopylae Holdings Ltd
56.13M
18.52%
+215.46K
+0.39%
Feb 27, 2026
Baker Bros. Advisors LP
27.53M
9.08%
--
--
Dec 31, 2025
Capital World Investors
13.36M
4.41%
--
--
Dec 31, 2025
Two Sigma Investments, LP
10.76M
3.55%
+769.18K
+7.70%
Dec 31, 2025
Lecault (Veronique)
9.61M
3.17%
--
--
Apr 01, 2025
UBS Asset Management (Americas) LLC
5.00M
1.65%
+5.00M
--
Dec 31, 2025
Goldman Sachs & Company, Inc.
4.34M
1.43%
+4.09M
+1636.29%
Dec 31, 2025
UBS Switzerland AG
1.93M
0.64%
-540.41K
-21.86%
Dec 31, 2025
ArrowMark Colorado Holdings, LLC
4.11M
1.35%
--
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Genomics Immunology and Healthcare ETF
2.64%
Virtus LifeSci Biotech Clinical Trials ETF
1.19%
ProShares Ultra Nasdaq Biotechnology
0.16%
Invesco Nasdaq Biotechnology ETF
0.16%
SPDR S&P International Small Cap ETF
0.12%
iShares Biotechnology ETF
0.11%
Invesco RAFI Developed Mkts ex-US SM ETF
0.05%
Avantis US Small Cap Equity ETF
0.01%
SPDR Portfolio Developed World ex-US ETF
0.01%
Fidelity Nasdaq Composite Index ETF
0.01%
View more
iShares Genomics Immunology and Healthcare ETF
Proportion2.64%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion1.19%
ProShares Ultra Nasdaq Biotechnology
Proportion0.16%
Invesco Nasdaq Biotechnology ETF
Proportion0.16%
SPDR S&P International Small Cap ETF
Proportion0.12%
iShares Biotechnology ETF
Proportion0.11%
Invesco RAFI Developed Mkts ex-US SM ETF
Proportion0.05%
Avantis US Small Cap Equity ETF
Proportion0.01%
SPDR Portfolio Developed World ex-US ETF
Proportion0.01%
Fidelity Nasdaq Composite Index ETF
Proportion0.01%